CONFORM Pivotal Trial Site Recruitment Meeting

Published: 16 June 2021

  • Views:

    Views Icon 661
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 661
  • Likes:

    Heart Icon 0

Overview

The CONFORM Pivotal Trial is a prospective, multi-center randomized controlled trial, designed to evaluate the safety and effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS®). Subjects will be randomized in a 1:1 fashion between the CLAAS device (treatment) or a Boston Scientific LAA closure device (Control).

 

If interested in participating in the Conform Pivotal Study, please contact Karis Oasan, Clinical Trial Manager koasan@conformalmedical.com.

 

For more information on Conformal Medical, Inc click HERE to visit our website.

This session is a clinical trial recruitment event.

Target Audience

  • Interventional Cardiologists
  • Electrophysiologists
  • All sites specialising in LAA procedures or doing research in this space

Series overview

Part 1

Welcome and Introductions

Presented by Andy Levine

1 session

Part 2

CLAAS Overview

Presented by Dr Aaron Kaplan

1 session

Part 3

Initial Clinical Experience

Presented by Dr Aaron Kaplan

1 session

Part 4

Case Study and Panel Discussion 1

Presented by Dr William Gray with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi

1 session

  • Case Study and Panel Discussion 1

    Watch now

Part 5

Case Study and Panel Discussion 2

Presented by Dr Vivek Reddy with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi

1 session

  • Case Study and Panel Discussion 2

    Watch now

Part 6

CONFORM Pivotal Trial Summary

Presented by Chris Cain

1 session

Part 7

Closing Remarks

Presented by Dr Aaron Kaplan

1 session

Faculty biographies